CAS 10161-87-2

4-(4-(2-Bromoacetamido)butyl)benzoic acid

CAS : 10161-87-2

4-(4-(2-Bromoacetamido)butyl)benzoic acid

Formule : C₁₃H₁₆BrNO₃

Degré de pureté : 98%

Masse moléculaire : 314.18

Ref: 54-OR1067734

KRA-533

CAS : 10161-87-2

4-(4-(2-Bromoacetamido)butyl)benzoic acid

Formule : C₁₃H₁₆BrNO₃

Degré de pureté : 98%

Masse moléculaire : 314.18

Ref: IN-DG01438738

Benzoic acid, 4-[4-[(2-bromoacetyl)amino]butyl]-

CAS : 10161-87-2

Formule : C₁₃H₁₆BrNO₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 314.1750

Ref: IN-DA0004YX

KRA-533

CAS : 10161-87-2

KRA-533 is an effective KRAS agonist that targets the GTP/GDP binding pocket within the KRAS protein, inhibiting GTP cleavage.

Formule : C₁₃H₁₆BrNO₃

Degré de pureté : 98.11%

Couleur et forme : Solid

Masse moléculaire : 314.18

Ref: TM-T38411

4-{4-[(Bromoacetyl)amino]butyl}benzoic acid

CAS : 10161-87-2

4-{4-[(Bromoacetyl)amino]butyl}benzoic acid is a ligand that binds to Ion channels. 4-{4-[(Bromoacetyl)amino]butyl}benzoic acid is a bidentate ligand, which interacts with the extracellular loops of the receptor. This compound has been shown to activate both potassium and chloride ion channels. 4-{4-[(Bromoacetyl)amino]butyl}benzoic acid has also been shown to inhibit the activity of beta adrenergic receptors, leading to hypotension and bradycardia in animals. 4-{4-[(Bromoacetyl)amino]butyl}benzoic acid is a high purity research tool that can be used for studying protein interactions, peptides, antibodies, cell biology and pharmacology.

Formule : C₁₃H₁₆BrNO₃

Degré de pureté : Min. 95%

Masse moléculaire : 314.17 g/mol

Ref: 3D-KAA16187